Ingevity Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Ingevity Stock Forecast and Price Target
Ingevity has an average price target of $50.00 recently offered by six notable experts for 2024, which would represent a potential upside of approximately 14.94% from the last closing price in April, 2024 if reached. This potential increase is based on a high estimate of $91.00 and a low estimate of $49.00. Even if you are not interested in NGVT stock, it is still crucial to be aware of its competitors.
14.94% Upside
Ingevity Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Ingevity has seen a decline in its Price, from $67.78 to $0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of $48.89, which would mean an increase of 100.00%. Over the next seven years, experts predict that Ingevity's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| XOM Stock Forecast | Exxon Mobil Corp | Outperform |
4
|
$118.52 | Buy/Sell | $124.27 | 8.42% |
| SHW Stock Forecast | Sherwin Williams | Outperform |
15
|
$309.38 | Buy/Sell | $317.38 | 9.81% |
| BAS Stock Forecast | BASF | Outperform |
12
|
51.07€ | Buy/Sell | 49.50€ | 9.65% |
| PPG Stock Forecast | PPG Industries | Outperform |
13
|
$135.11 | Buy/Sell | $159.04 | 18.42% |
| REP Stock Forecast | Repsol | Outperform |
16
|
15.05€ | Buy/Sell | 17.01€ | 16.28% |
Ingevity Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Ingevity's Revenue has grown by 39.14%, rising from $1.22B to $1.69B. According to the 7 analysts polled, in the next year, Ingevity's Revenue will fall by 8.06%, reaching $1.56B. By 2030, professionals believe that Ingevity's Revenue will have decreased by 7.72%, falling to $1.56B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EMN Stock Forecast | Eastman Chemical Co | Outperform |
11
|
$96.02 | Buy/Sell | $96.03 | 5.19% |
| 9532 Stock Forecast | Osaka Gas | Outperform |
15
|
¥3.23k | Buy/Sell | ¥2.94k | 17.54% |
| AKE Stock Forecast | Arkema | Outperform |
18
|
97.35€ | Buy/Sell | 110.07€ | 12.99% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 3405 Stock Forecast | Kuraray | Outperform |
17
|
¥1.51k | Buy/Sell | ¥0.00 | 19.56% |
| 4202 Stock Forecast | Daicel | Outperform |
16
|
¥1.44k | Buy/Sell | ¥0.00 | 14.74% |
| BRG Stock Forecast | Borregaard ASA | Outperform |
18
|
kr191.20 | Buy/Sell | kr182.25 | 9.83% |
Ingevity EBITDA Forecast for 2023 - 2025 - 2030
Ingevity's EBITDA has decreased In the last three years, from $393.30M to $378.90M – a 3.66% drop. In the following year, 6 experts forecast Ingevity's EBITDA will decrease by 0.41%, to $377.33M. For the next seven years, the forecast is for EBITDA to grow by 16.75%.
Ingevity EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Ingevity's EBIT has seen a drop from $293.10M to $256.10M – a 12.62% decrease. According to 6 major analysts, Ingevity's EBIT will fall by 0.78% in the next year, reaching $254.10M. Over the next seven years, experts believe that Ingevity's EBIT will grow at a rate of 21.45%.
Ingevity EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Ingevity has seen a decline in its EPS, from $4.88 to $0.00 – a 100.00% decrease. For next year, analysts predict EPS of $3.52, which would mean an increase of 100.00%. Over the next seven years, experts predict that Ingevity's EPS will grow at a rate of 100.00%.
.jpg)